Open AccessIncreased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes
Author(s) -
K O Tofiq,
Nailya Y. Bulatova,
Violet Kasabri,
Maysa Suyagh,
Lana Halaseh,
Sundos AlAlawi
Publication year - 2019
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2018_139
Subject(s) - prediabetes , medicine , endocrinology , metabolic syndrome , insulin resistance , waist , diabetes mellitus , body mass index , type 2 diabetes
The neuropeptide hormone- Oxytocin (OXT) and glycoprotein Lipocalin-2 (LCN-2) are strongly associated with cardiometabolic risks of insulin resistance in metabolic syndrome (MetS) and prediabetes (preDM).